Science in Action services

SIA`s philanthropic research supports the Israeli Duchenne Parent Association. This is an eort to develop a cure for Duchenne Muscular Dystrophy (DMD). DMD is the most common, fatal genetic disorder diagnosed in childhood. It aects approximately 1 in every 3,500 male infants born. We invite you to read more about SIA’s Philanthropic DMD Research and Duchenne Animal Models.

Our clients and partners include medical device, pharmaceutical and biotechnology organizations. We help to accelerate the process of bringing your new product to market with the experience, resources and global reach of SCOPUS team.

We work according to current ICH-GCP requirements, all applicable local and global laws and guidelines.

Project phase:; Medical devices: First in Human (FIH), pivotal studies. Pharmaceuticals: FIH, Phase I-IV.

In vitro migration and invasion assays provide a simple and fast quantitative platform to measure cellular migratory or invasive phenotypes, in vitro. In this assay, cells are allowed to migrate through an artificial membrane towards a chemo-attractant gradient. The efficiency of this process is assessed by fluorometric analysis. Migration through a membrane coated with basement membrane components provides a model system to study invasive potential of the cell culture.